PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 29 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,591 | -17.0% | 158,790 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $317,580 | +13.0% | 158,790 | +18.7% | 0.01% | +14.3% |
| Q1 2023 | $280,959 | +53.3% | 133,790 | 0.0% | 0.01% | +40.0% |
| Q4 2022 | $183,292 | +31.9% | 133,790 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $139,000 | -19.7% | 133,790 | -15.7% | 0.00% | 0.0% |
| Q2 2022 | $173,000 | +458.1% | 158,790 | +451.5% | 0.00% | +300.0% |
| Q1 2022 | $31,000 | -60.3% | 28,790 | -51.1% | 0.00% | 0.0% |
| Q3 2021 | $78,000 | -89.6% | 58,890 | -85.0% | 0.00% | -92.3% |
| Q2 2021 | $752,000 | -44.3% | 393,890 | +30.2% | 0.01% | -48.0% |
| Q1 2021 | $1,350,000 | +74.9% | 302,591 | +42.3% | 0.02% | +56.2% |
| Q4 2020 | $772,000 | -6.2% | 212,591 | 0.0% | 0.02% | -15.8% |
| Q3 2020 | $823,000 | +24.5% | 212,591 | +22.0% | 0.02% | +46.2% |
| Q2 2020 | $661,000 | +214.8% | 174,291 | +94.8% | 0.01% | +160.0% |
| Q1 2020 | $210,000 | – | 89,492 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spire Wealth Management | 148,800 | $158,000 | 0.00% |
| MEITAV INVESTMENT HOUSE LTD | 244,332 | $257,000 | 0.00% |
| Phoenix Holdings Ltd. | 244,113 | $259,000 | 0.00% |
| IHT Wealth Management, LLC | 24,000 | $25,000 | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
| Virtu Financial LLC | 15,199 | $16,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 41,574 | $44,000 | 0.00% |
| Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 28,790 | $31,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,153 | $5,000 | 0.00% |